Printer Friendly

Hypertension risk soars in offspring of early-HT parents.

NEW ORLEANS--Young adults whose parents develop hypertension before age 55 years are themselves at sharply increased risk of developing the disease, according to a report from the Framingham (Mass.) Heart Study.

"Our results demonstrate that early-onset but not late-onset hypertension in parents is a strong risk factor for incident hypertension. It may be important for physicians to distinguish between early- and late-onset hypertension as a familial trait when assessing an individual's risk for hypertension," Teemu J. Niiranen, MD, said at the American Heart Association scientific sessions.

Compared with the offspring of Framingham participants who were normotensive, those with one parent who developed hypertension before age 55 years were at twofold increased risk of subsequent hypertension. If both parents had hypertension before age 55 years, the risk in their offspring was 3.5-fold greater than when both parents were normotensive, according to Dr. Niiranen of Boston University.

He reported on 1,635 participants in the offspring cohort of the Framingham Heart Study who were normotensive when they enrolled in the prospective study beginning in 1972. At that time, they averaged 32 years of age. They were followed for a mean of 26 years.

Like their parents who enrolled in the original cohort of the landmark study beginning in 1948, they underwent meticulous blood pressure measurement roughly every 2 years.

Dr. Niiranen and his coinvestigators divided the offspring cohort into four groups based upon parental hypertension status. There were 107 offspring with normotensive parents, 480 with one or both parents having developed late-onset hypertension after age 55 years, 721 offspring who had one parent with onset of hypertension before age 55 years, and 327 with both parents having early-onset hypertension.

The incidence rate of hypertension in the offspring cohort climbed in concert with parental early hypertension status. So did the multivariate-adjusted relative risk of the disease, compared with children of normotensive parents.

Moreover, the earlier in life the parents developed hypertension, the earlier their offspring did, too.

Session moderator David J. Maron, MD, of Stanford (Calif.) University, commented, "Everybody's thinking 'genetics' as we look at your findings. But do you have any way to tease out nature versus nurture in understanding the association?"

Dr. Niiranen replied that in a separate study of three generations of Framingham participants, the investigators incorporated two lifestyle factors in their analysis: level of exercise and sodium intake.

"Those didn't have much effect on the results, so it seems like genetics is driving most of the outcome," he said.

Dr. Niiranen reported having no financial conflicts of interest regarding his study, sponsored by the National Heart, Lung, and Blood Institute.

bjancin@frontlinemedcom.com

BY BRUCE JANCIN

AT THE AHA SCIENTIFIC SESSIONS
Parental hypertension history predicts risk in offspring

Both normotensive
(n = 107)                  HR, 1.0 (ref.)
Hypertension onset after
55 in one or both parents
(n = 480)                  HR, not significant
Onset before 55 in
one parent (n = 721)       HR,2.0
Onset before 55 in
both parents (n = 327)     HR,3.5

Hypertension incidence per 1,000 person-years in offspring

Notes: Subjects were followed for a mean of 26 years. Hazard ratio
(HR) adjusted for age, sex, BMI, systolic and diastolic blood
pressure, smoking status, total cholesterol, and HDL.
Source: Dr. Niiranen
COPYRIGHT 2017 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:CARDIOLOGY
Author:Jancin, Bruce
Publication:Family Practice News
Geographic Code:1USA
Date:Feb 15, 2017
Words:534
Previous Article:Cardiologist care for newly diagnosed AF improves outcomes.
Next Article:Spironolactone holds its own for treating women's acne.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters